MPWT
FOLD

MassMutual Private Wealth & Trust’s Amicus Therapeutics FOLD Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-453
Closed -$6.55K – 2431
2026
Q1 		$6.55K Hold
453
– – ﹤0.01% 1553
2025
Q4 		$6.45K Hold
453
– – ﹤0.01% 1572
2025
Q3 		$3.57K Buy
453
+225
+99% +$1.6K ﹤0.01% 1802
2025
Q2 		$1.31K Sell
228
-405
-64% -$2.61K ﹤0.01% 2059
2025
Q1 		$5.17K Buy
633
+554
+701% +$5.13K ﹤0.01% 1589
2024
Q4 		$744 Buy
+79
New +$821 ﹤0.01% 2090
2024
Q3 		– Sell
-380
Closed -$3.77K – 2181
2024
Q2 		$3.77K Buy
380
+273
+255% +$2.8K ﹤0.01% 1412
2024
Q1 		$1.26K Buy
107
+29
+37% +$371 ﹤0.01% 1654
2023
Q4 		$1.11K Buy
+78
New +$886 ﹤0.01% 1660
2018
Q3 		– Sell
-300
Closed -$4.69K – 1021
2018
Q2 		$4.69K Hold
300
– – ﹤0.01% 737
2018
Q1 		$4.51K Sell
300
-700
-70% -$10.7K ﹤0.01% 722
2017
Q4 		$14.4K Hold
1,000
– – ﹤0.01% 570
2017
Q3 		$15.1K Buy
+1,000
New +$13.2K ﹤0.01% 691

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MassMutual Private Wealth & Trust's FOLD Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 453 shares — an estimated $6.55K sold.

MassMutual Private Wealth & Trust first reported a position in FOLD in Q3 2017 and held it in 13 quarters. The position peaked at $15.1K in Q3 2017. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • MassMutual Private Wealth & Trust reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 453 Amicus Therapeutics shares in Q2 2026, an estimated $6.55K.
  • MassMutual Private Wealth & Trust first reported a position in Amicus Therapeutics in Q3 2017 and held it in 13 quarters.
  • MassMutual Private Wealth & Trust's Amicus Therapeutics position peaked at $15.1K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.